Safety and Efficacy of SHPL-49 Injection in Participants With Acute Ischemic Stroke
Clinical trial NCT06202378 · COMPLETED
Trial details
- NCT number
- NCT06202378
- Sponsor
- Shanghai Hutchison Pharmaceuticals Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-29
- Primary completion
- 2024-11-26
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.